Beranda › Skleroderma › Massachusetts › Boston
Uji klinis Skleroderma di Boston, MA
7 studi untuk Skleroderma mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Menerima pesertaFase 3
- Massachusetts General Hospital, Boston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Menerima pesertaFase 1
- Boston Medical Center, Boston
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- Massachusetts General Hospital, Boston
- Boston University (BU), Boston
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
Menerima pesertaSukarelawan sehat diterima
- Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Menerima pesertaFase 1
- Brigham And Womens Hospital, Boston
Open Label Treprostinil Raynaud's Study
Menerima pesertaFase 4
- Brigham and Women's Hospital, Boston
- Brigham and Women's Hospital, Boston
Uji klinis Skleroderma di kota lain
- New York City, NY11 studi
- Chicago, IL10 studi
- Ann Arbor, MI10 studi
- Houston, TX9 studi
- Durham, NC7 studi
- Los Angeles, CA7 studi
- Baltimore, MD6 studi
- New Orleans, LA6 studi
- Philadelphia, PA6 studi
- Pittsburgh, PA5 studi
- Dallas, TX5 studi
- Phoenix, AZ4 studi
Studi lain di Boston
- Kanker Payudara111 studi
- Kanker Paru Non-Sel Kecil89 studi
- Kanker (semua jenis)86 studi
- Kanker Kolorektal63 studi
- Kanker Metastatik63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat60 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Leukemia Mieloid Akut44 studi
- Kanker Pankreas44 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.